What PGIM India Healthcare Fund bought and sold in September 2026
This compares the fund's portfolio at the end of September 2026 with the month before. Both come from the monthly portfolio statement of PGIM India Mutual Fund.
PGIM India Healthcare Fund Stocks Bought and Sold
All changes are between August 2026 and September 2026
More
| Divi's Laboratories Ltd. | Added | +1.3% | 10.36% |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Added | +8.6% | 10.25% |
| Torrent Pharmaceuticals Ltd. | Added | +5.3% | 8.49% |
| Max Healthcare Institute Ltd. | Added | +10.9% | 4.71% |
| Ajanta Pharma Ltd. | Added | +6.5% | 4.96% |
| Dr. Lal Path Labs Ltd. | Added | +11.7% | 4.33% |
| Rubicon Research Ltd. | Reduced | −12.8% | 2.99% |
| Navin Fluorine International Ltd. | Added | +16.6% | 3.24% |
| Abbott India Ltd. | Added | +9.5% | 3.12% |
| Pfizer Ltd. | Sold out | −100% | was 2.12% |
| ICICI Lombard General Insurance Co. Ltd. | Added | +54.3% | 2.10% |
| Zydus Lifesciences Ltd. | Added | +40.8% | 2.04% |
| Lupin Ltd. | Added | +52.7% | 1.93% |
| IPCA Laboratories Ltd. | Added | +304.7% | 1.92% |
| Dr Agarwal's Eye Hospital Ltd. | Added | +66.2% | 1.86% |
| Gland Pharma Ltd. | Added | +111.8% | 1.50% |
| Fortis Healthcare Ltd. | Added | +62.5% | 1.46% |
| Symbiotec Pharmalab Ltd. | New | New | 1.10% |
| Lenskart Solutions Ltd. | Added | +38.9% | 0.99% |
| Dr Agarwal's Health Care Ltd. | Sold out | −100% | was 0.86% |
| Molbio Diagnostics Ltd. | New | New | 0.80% |
No stocks in this group for September 2026.
A change is counted by the number of shares the fund holds, not by price. A stock can become a smaller part of the fund in a month when the fund bought more of it, if its price fell. Debt papers are left out.
Frequently Asked Questions
Which new stocks did PGIM India Healthcare Fund buy in September 2026?
It bought 2 new stocks: Symbiotec Pharmalab Ltd (1.10%) and Molbio Diagnostics Ltd (0.80%). Each figure is the stock's share of the fund at the end of September 2026.
Which stocks did PGIM India Healthcare Fund sell completely in September 2026?
It sold all its shares in Pfizer Ltd (2.12%) and Dr Agarwal's Health Care Ltd (0.86%). Each figure is the stock's share of the fund at the end of August 2026.
Which stocks did PGIM India Healthcare Fund buy more of in September 2026?
The largest increases in shares held were IPCA Laboratories Ltd (+304.7%), Gland Pharma Ltd (+111.8%), Dr Agarwal's Eye Hospital Ltd (+66.2%), Fortis Healthcare Ltd (+62.5%) and ICICI Lombard General Insurance Co. Ltd (+54.3%). It added to 11 more.
Which stocks did PGIM India Healthcare Fund sell part of in September 2026?
The largest cuts in shares held were Rubicon Research Ltd (−12.8%).
How are these changes worked out?
WealthGamma compares the number of shares PGIM India Healthcare Fund held on 30-09-2026 with 31-08-2026. Both figures come from the monthly portfolio statement of PGIM India Mutual Fund. A change in share price alone does not count as buying or selling.
See NAV, expense ratio and full holdings of PGIM India Healthcare Fund
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.